January 16, 2021
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following President-elect Biden’s introduction of a COVID-19 vaccination plan.
Healthcare Distribution Alliance – Patients Move Us.
SEARCH
News
FEATURED NEWS
HDA Statement on Biden Administration COVID-19 Relief and Vaccine Distribution Plan
January 16, 2021
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following President-elect Biden’s introduction of a COVID-19 vaccination plan.
HDA Statement on COVID-19 Emergency Relief Package
December 22, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate.
HDA Statement on FDA Authorization of Moderna Vaccine
December 18, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization for the Moderna COVID-19 vaccine...
HDA Pharmaceutical Distributors Manage 93 Percent of 2019 U.S. Sales
December 3, 2020
Data published today by the HDA Research Foundation reveal an estimated 93 percent of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As...
-
HDA Statement on Biden Administration COVID-19 Relief and Vaccine Distribution Plan
-
HDA Research Foundation Names Supply Chain ScholarsJanuary 13, 2021
The HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders.
-
HDA Statement on COVID-19 Emergency Relief PackageDecember 22, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate.
-
HDA Statement on FDA Authorization of Moderna VaccineDecember 18, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization for the Moderna COVID-19 vaccine candidate.
-
HDA Statement on FDA Authorization of First COVID-19 VaccineDecember 11, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the U.S. Food and Drug Administration’s (FDA) decision to grant Emergency Use Authorization of the first COVID-19 vaccine, manufactured by Pfizer and BioNTech.
Media Contacts
John Parker
(703) 885-0216
Farah Simonett
(703) 885-0269
